These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36681816)

  • 41. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
    Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
    Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
    Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
    Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
    Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
    Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y
    Leonardi GR; Lescano CH; Costa JL; Mazetto B; Orsi FA; Monica FZ
    J Thromb Haemost; 2022 Jul; 20(7):1699-1711. PubMed ID: 35395698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.
    Giusti B; Gori AM; Marcucci R; Saracini C; Sestini I; Paniccia R; Valente S; Antoniucci D; Abbate R; Gensini GF
    Pharmacogenet Genomics; 2007 Dec; 17(12):1057-64. PubMed ID: 18004210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the Newly Developed Adenosine Diphosphate-Induced Platelet Aggregation Level System in Aggregometer on Automated Coagulation Analyzer.
    Sakayori T; Kitano K; Watanabe Y; Omori Y; Ishida H; Arai N; Uematsu K; Enomoto Y; Komiyama Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction.
    Serebruany VL; Gurbel PA; Shustov AR; Ohman EM; Topol EJ
    Am Heart J; 1998 Sep; 136(3):398-405. PubMed ID: 9736129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The naphthoquinone plumbagin suppresses ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathway.
    Zhang Q; Liao X; Wu F
    Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):573-578. PubMed ID: 28650323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased platelet inhibition by P2Y12 receptor blockers in anaemia.
    Wadowski PP; Kopp CW; Koppensteiner R; Lang IM; Pultar J; Lee S; Weikert C; Panzer S; Gremmel T
    Eur J Clin Invest; 2018 Jan; 48(1):. PubMed ID: 29171876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor.
    Bouman HJ; van Werkum JW; Rudez G; Leebeek FW; Kruit A; Hackeng CM; Ten Berg JM; de Maat MP; Ruven HJ
    Thromb Haemost; 2010 Feb; 103(2):379-86. PubMed ID: 20126830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
    Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
    Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADP-induced platelet aggregation in young female survivors of acute myocardial infarction and their female controls.
    Vilén L; Johansson S; Kutti J; Cronberg S; Vedin A; Wilhelmsson C
    Acta Med Scand; 1985; 217(1):9-13. PubMed ID: 3976437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of intracellular signaling events in ADP-induced platelet aggregation.
    Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
    Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
    Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
    Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.
    Sionova M; Blasko P; Jirous S; Vindis D; Rokyta R; Motovska Z
    Postepy Kardiol Interwencyjnej; 2017; 13(3):202-209. PubMed ID: 29056992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
    Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
    Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diverse signalling of the platelet P2Y
    Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
    Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.